Former President Donald Trump claimed that he convinced French President Emmanuel Macron to raise drug prices in France as a strategic move to influence drug pricing in the United States. Trump stated that he told Macron, “you have to raise your drug prices,” and when Macron initially refused, Trump suggested that he would impose a 25% tariff on all French goods imported into the U.S. if he did not comply.
Trump’s remarks suggest a linkage between international drug price policies and tariffs, implying that he sought to leverage France’s drug pricing to ultimately benefit American consumers. The details of any actual policy changes or negotiations remain unclear, and statements from Macron or French officials have not been publicly confirmed.
This claim comes amid ongoing debates over drug pricing and trade policies between the U.S. and other countries. Critics may view Trump’s statement as an oversimplification of complex international trade and pharmaceutical markets. The exchange underscores how negotiations over drug costs can sometimes involve diplomatic and trade considerations beyond domestic policy.
As of now, there has been no official response from French authorities, and the veracity of Trump’s account has not been independently verified. The story highlights the ongoing tensions surrounding global drug prices and the use of tariffs as bargaining tools in international relations.